The Tolbert Lab, in collaboration with researchers from Duke University and Rutgers University, have identified a potential drug candidate against Enterovirus 71 (EV71), a pathogen with no FDA-approved drug or vaccine. The compound of interest binds to the viral RNA which induces a conformational change that inhibits viral replication.
This work...
